Lacey, WA - As the European Union harmonizes its policies regulating nutraceuticals, cosmeceuticals and functional foods, Unigen Pharmaceuticals, a leading US natural products R&D company, has recently established an office in Brussels to play an important part in the process.
Brussels is both the capital of Belgium and the seat of the EU Parliament. The city also has a long history of supporting botanicals with nutritional functionality supported by science. By opening an office in this important geographical and political center, Unigen feels it has a role to play in offering its unique business model to the vibrant market of Central, Eastern and Western Europe.
Unigen Vice President of Sales and Marketing, Doug Lynch, comments, “This move is but the first step of a major initiative in Europe by Unigen. We are intent on replicating our successes that we have had in Asia and North America. Unigen is committed to bringing patented, safe and efficacious ingredients, all discovered in natural products, to our strategic partners in Europe.”
Unigen places a high premium on the importance of vertical integration in the research and manufacturing of its products. They focus on a model of discovery and full safety and efficacy trials to ensure the very highest product quality in this booming market. Their Phytologix® library containing over 10,000 medicinal plants and thousands of extracts, has yielded many important discoveries with applications for animal health, functional foods and beverages, nutraceuticals and cosmeceutical products. In addition, Unigen is committed to allowing access to the library for strategic partners based in Europe.
Lynch also points out that the new office will offer their European customers direct technical, marketing, sales and regulatory assistance.
About Unigen Pharmaceuticals, Inc.
www.unigenUSA.com – Unigen Pharmaceuticals, Inc. is a leading natural products research and development company and proprietary ingredients supplier. The Company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve quality of life.
Their research and discovery includes extensive work at both the human cell and gene level. Unigen focuses on identifying and studying the unique ingredients of medicinal botanicals and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical, functional food and pharmaceutical products.
Unigen’s global offices include 80 employees, 55 of whom are scientists. Contributing to their vast library of novel botanical ingredients, the current facilities include high-throughput screening and cell culture labs, bioprospecting labs and a large-scale manufacturing facility. Unigen is part of the ECONET global family of health and natural product companies, which has operations in the United States, Canada, Korea, Mexico, Russia and China.
- # # # -